Institutional Registry of Haemorrhagic Hereditary Telangiectasia

Recruiting Observational Study
Haemorrhagic Hereditary Telangiectasia
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
590 (estimated)
Sponsor
Hospital Italiano de Buenos Aires · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to create an institutional and population-based registry of Haemorrhagic Hereditary Telangiectasia with a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival. This study will also describe the occurrence of Haemorrhagic Hereditary Telangiectasia in the population of HIBA in the Central Hospital, as w…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients with HHT defined. 2. Followed in Unidad HHT of Hospital Italiano de Buenos Aires. Exclusion Criteria: 1\. Denied to participated in the registry or inform consent process.
Contacts

Marcelo M Serra, MD

+541149590200

marcelo.serra@hospitalitaliano.org.ar

CONTACT

Diego H Giunta, MD

+541149590200

diego.giunta@hospitalitaliano.org.ar

CONTACT